| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma
|
Goussen, Caroline
|
|
2017
|
31 |
3 |
p. 251-261
|
artikel
|
| 2 |
Biosimilars in the United States: Emerging Issues in Litigation
|
Wong, Alice Yuen-Ting
|
|
2017
|
31 |
3 |
p. 189-205
|
artikel
|
| 3 |
Chronic Myeloid Leukemia: Immunobiology and Novel Immunotherapeutic Approaches
|
Cayssials, Emilie
|
|
2017
|
31 |
3 |
p. 143-149
|
artikel
|
| 4 |
CT-P10 (Truxima™): A Rituximab Biosimilar
|
Deeks, Emma D.
|
|
2017
|
31 |
3 |
p. 275-278
|
artikel
|
| 5 |
Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community
|
Markus, Richard
|
|
2017
|
31 |
3 |
p. 175-187
|
artikel
|
| 6 |
Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents
|
Reinisch, Walter
|
|
2017
|
31 |
3 |
p. 223-237
|
artikel
|
| 7 |
Golimumab: A Review in Inflammatory Arthritis
|
Frampton, James E.
|
|
2017
|
31 |
3 |
p. 263-274
|
artikel
|
| 8 |
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering
|
Yu, Xiaojie
|
|
2017
|
31 |
3 |
p. 151-166
|
artikel
|
| 9 |
Interleukin-1 Blockade: An Update on Emerging Indications
|
Mistry, Anoop
|
|
2017
|
31 |
3 |
p. 207-221
|
artikel
|
| 10 |
Interleukin-1 Blockade: An Update on Emerging Indications
|
Mistry, Anoop
|
|
|
31 |
3 |
p. 207-221
|
artikel
|
| 11 |
PCSK9 Inhibitors in Hyperlipidemia: Current Status and Clinical Outlook
|
Di Bartolo, Belinda
|
|
2017
|
31 |
3 |
p. 167-174
|
artikel
|
| 12 |
Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain
|
DaSilva, Iara
|
|
2017
|
31 |
3 |
p. 239-249
|
artikel
|
Tijdschrift beschrijving